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http://dx.doi.org/10.1016/j.jmii.2013Introduction: The association between e336 A/G polymorphism of CD209 and susceptibility
to/protection from tuberculosis is inconsistent.
Aim: The present study aimed at evaluating the possible association between CD209 rs4804803
(e336A/G)genepolymorphismandpulmonary tuberculosis (PTB) ina sampleof Iranianpopulation.
Materials and methods: This caseecontrol study was performed on 156 PTB patients and 154
healthy individuals. Tetra-amplification refractory mutation system-polymerase chain reaction
was used to detect the polymorphisms.
Results: Our findings revealed that the CD209 rs4804803 increased the risk of PTB in codominant
[odds ratio (OR)Z 5.16, 95% confidence interval (CI)Z 1.60e16.59, pZ 0.006, GG vs. AA], domi-
nant (ORZ 1.69, 95% CIZ 1.07e2.66, pZ 0.024, AGþ GG vs. AA), and recessive (ORZ 4.20, 95%
CIZ 1.34e13.16, pZ 0.014, GG vs. AA þ AG) tested inheritance models. Furthermore, thet of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan
mail.com, hashemim@zaums.ac.ir (M. Hashemi).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
.03.013
172 M. Naderi et al.rs4804803 G allele increased the risk of PTB (ORZ 1.58, 95% CIZ 1.12e2.23, pZ 0.011) as
compared to the A allele.
Conclusion: Our data suggest that CD209 rs4804803 polymorphism increased the risk of PTB in a
sample of Iranian population.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction written informed consent was obtained from all partici-
pants. All control individuals were from the sameTable 1 Primers used for the detection of single-
nucleotide polymorphism of DC-SIGN rs4804803
polymorphism








Reverse outer AGATGGGCCGGATCTTTCAAGAATTTTuberculosis (TB) is a global public health problem and
remains a major cause of death worldwide, especially in
Asia and Africa. One-third of the world’s population is
infected with Mycobacterium tuberculosis. However, only
approximately 5e10% of those infected develop the active
disease in their lifetime.1 TB is a highly complex disease,
and the reason why some infected individuals develop
active disease, while others do not is not yet understood
completely. Although pathogens and environmental factors
are supposed to contribute to TB, increasing evidence
suggests that host genetic factors play a significant role in
TB susceptibility.2e4 Genetic studies on TB have shown that
the genetic polymorphisms, potentially involved in the
immune response to TB, may lead to susceptibility to or
protection from TB. The DC-SIGN gene is located on chro-
mosome 19p13.2e3. DC-SIGN might be a key part of the
host immunity to TB and one of the candidate genes for
susceptibility to TB. DC-SIGN is mainly expressed on den-
dritic cells (DCs) and alveolar macrophages. DCs are pro-
fessional antigen presenting cells playing a crucial role in
connecting innate and adaptive immunity.5 DC-SIGN acts as
a major receptor for M. tuberculosis in human DCs and
plays an important first-line role in host defense against
pathogens, by internalization and presentation of the
bacterium.6 In mature DCs, DC-SIGN promotes the activa-
tion and proliferation of resting T cells and increases pri-
mary immune responses.7
Although, possible genetic associations between TB and
e366 A/G polymorphism of CD209 have been investigated in
previous studies, the findings are contradictory.8e12 Ge-
netic risk factors for TB may differ among different pop-
ulations. Subsequently, previously reported genetic
associations in other populations should be investigated
repeatedly to determine the associations of the genetic risk
in each population. Although, the associations between
CD209 e336A/G polymorphism and the risk of TB have been
studied, the findings are controversial.9,10,13e15 To the best
of our knowledge, there is no report regarding the impact
of this polymorphism on susceptibility to TB in Iranian
population. Therefore, the present study was conducted to
find out the possible association between e366 A/G poly-
morphism of CD209 and the risk of/protection from
pulmonary tuberculosis (PTB) in a sample of Iranian
population.
Materials and methods
This caseecontrol study was conducted in 156 patients with
PTB and 154 healthy individuals, in the Research Center for
Infectious Diseases and Tropical Medicine, Bou-Ali Hospital,
Zahedan, Iran. The local ethics committee of the Zahedan
University of Medical Sciences approved the project, andgeographical origin and living in the same region as the
patients with PTB (Zahedan, southeast Iran).
The diagnosis of PTB was based on clinical symptoms,
radiological evidence, and bacteriological investigations
such as sputum acid-fast bacillus smear positivity, culture,
and response to anti-TB chemotherapy, as described pre-
viously.16,17 Whole-blood samples were collected in sodium-
ethylenediaminetetraacetic acid (Na-EDTA) tubes from all
participants and genomic DNA was extracted as described
previously.18
The CD209 genomic sequence (NT_077812.2) was ob-
tained from the National Center for Biotechnology Infor-
mation (NCBI). The rs4804803 polymorphism was searched,
and primers for tetra-primer amplification refractory mu-
tation system-polymerase chain reaction (T-ARMS-PCR)
were designed (Table 1). This method is a rapid and simple
technique for detection of single-nucleotide poly-
morphism.19e21 In T-ARMS-PCR method, four primers (two
external primers and two allele-specific internal primers)
were used. Product sizes were 197 bp for the G allele,
292 bp for the A allele, and 442 bp for the control band.
PCR was performed using a PCR premix (AccuPower PCR
PreMix, Bioneer, Daejeon, Korea). Into a 0.2-mL PCR tube
containing the AccuPower PCR PreMix, 1 mL template DNA
(w100 ng/mL), 1 mL of each primer (10 mM), and 15 mL
DNase-free water were added. PCR was performed under
the following conditions: 95C for 5 minutes; 95C for 30
seconds, 61C for 25 seconds, 72C for 30 seconds, 30 cy-
cles; and 72C for 10 minutes. The PCR products were
electrophoresed on 2% agarose gels and photographed
(Fig. 1). We regenotyped random samples to verify the
accuracy of genotyping. No genotyping mistake was found.
Statistical analysis
The statistical analysis of the data was performed using
the SPSS 18.0 software (SSPS Inc., Chicago, IL, USA).
Demographics and biochemical parameters between the
Figure 1. Electrophoresis pattern of T-ARMS-PCR for detec-
tion of e366 A/G (rs4804803) polymorphism of DC-SIGN. Lane
1Z GG; Lane 2Z AG; Lane 3Z AA; MZ DNA marker; T-ARMS-
PCR Z tetra-amplification refractory mutation system-
polymerase chain reaction.
CD209 polymorphism in pulmonary tuberculosis 173groups were analyzed by independent sample t tests for
continuous data and c2 test for categorical data. The as-
sociations between genotypes and PTB were estimated by
computing the odds ratio (OR) and 95% confidence interval
(95% CI) from logistic regression analyses. A p value of less
than 0.05 was considered statistically significant.Results
A total of 156 PTB patients (58 males and 98 females; aged
48.1  15.6 years) and 154 healthy individuals (67 males
and 87 females; aged 49.8  20.7 years) were enrolled in
the study. There was no significant difference between the
groups regarding age and sex (p Z 0.403 and p Z 0.297,
respectively). The genotype and allele frequencies of
CD209 rs4804803 polymorphism in PTB patients and control
individuals are shown in Table 2. A significant difference
was found between PTB patients and controls regarding
CD209 rs4804803 polymorphism (c2 Z 9.21, df Z 2,
p Z 0.010).Table 2 Frequency distribution of DC-SIGN rs4804803 gene poly
Genotypes PTB n (%) Controls n (%) OR (95%
Codominant
AA 61 (39.1) 79 (51.3) 1.00
AG 80 (51.3) 71 (46.1) 1.46 (0.
GG 15 (9.6) 4 (2.6) 4.86 (1.
Dominant
AA 61 (39.1) 79 (51.3) 1.00
AG þ GG 95 (60.9) 75 (48.7) 1.64 (1.
Recessive
AA þ AG 141 (91.4) 150 (97.4) 1.00
GG 15 (9.6) 4 (2.6) 3.99 (1.
Alleles
A 202 (46.7) 229 (74.4) 1.00
G 110 (53.3) 79 (25.6) 1.58 (1.
a Adjusted for sex and age.
CI Z confidence interval; OR Z odds ratio; PTB Z pulmonary tubercOur findings showed that CD209 rs4804803 polymorphism
increased the risk of PTB in codominant (OR Z 5.16, 95%
CI Z 1.60e16.59, p Z 0.006, GG vs. AA), dominant
(OR Z 1.69, 95% CI Z 1.07e2.66, p Z 0.024, AG þ GG vs.
AA), and recessive (OR Z 4.20, 95% CI Z 1.34e13.16,
p Z 0.014, GG vs. AA þ AG) tested inheritance models.
Furthermore, the rs4804803 G allele increased the risk of
PTB (OR Z 1.58, 95% CI Z 1.12e2.23, p Z 0.011) as
compared to the A allele.Discussion
In the present study, we examined the impact of rs4804803
DC-SIGN polymorphism on the risk of PTB in a sample of
Iranian population. Our findings showed that GG genotype
as well as the G allele increased the risk of PTB in our
population. In agreement with our finding, Barreiro et al8
reported that e336 A decreased the risk of developing TB
in a cohort of individuals of South African colored origin. By
contrast, Vannberg et al10 observed that e336 G exhibited
significant protection against pulmonary TB in sub-Saharan
Africa. In contrast to our finding, Olesen et al,11 in the north
African city of Tunis, and Ben-Ali et al,9 in the west African
city of Guinea-Bissau, found no association between e336
A/G polymorphism and TB. Furthermore, Zheng et al12 have
found that e336A/G (rs4804803) polymorphism of DC-SIGN
is not associated with susceptibility to TB in Chinese pop-
ulation. Kobayashi et al22 have found no association be-
tween this variant and the risk of TB in Indonesian
population. Gomez et al23 reported that e336 A/G variant
did not increase the risk of TB in non-African individuals
from northwestern Colombia,.
During preparation of this manuscript, two meta-
analyses were published. A meta-analysis of 10 studies
(2598 TB patients and 2614 control individuals) performed
by Miao et al13 found no association between CD209
e336A/G polymorphism and the risk of TB (ORZ 1.02, 95%
CI Z 0.90e1.15, for G vs. A allele). Another meta-analysis
was carried out by Chang et al.,15 based on the data
extracted from 14 studies (3610 cases and 3539 controls).
They observed that CD209 promoter e336A/Gmorphisms in PTB and healthy individuals (control)
CI) p OR (95% CI) a p
d 1.00 d
92e2.32) 0.109 1.49 (0.94e2.39) 0.090
53e15.37) 0.007 5.16 (1.60e16.59) 0.006
d 1.00 d
06e2.58) 0.031 1.69 (1.07e2.66) 0.024
d 1.00 d




174 M. Naderi et al.polymorphism was not associated with TB susceptibility in
all genetic models (OR Z 1.04, 95% CI Z 0.91e1.19 for G
vs. A; OR Z 1.13, 95% CI Z 0.84e1.53 for GG vs. AA;
OR Z 1.04, 95% CI Z 0.87e1.24 for GG þ AG vs. AA; and
OR Z 1.11, 95% CI Z 0.88e1.39 for GG vs. AG þ AA).
Analyzing the association between CD209 e336A/G poly-
morphism and the risk of TB in different ethnicities, they
found that the GG genotype increased the risk of TB in
Asians.15 Our result is in agreement with this finding.
Ogarkov et al24 have found a correlation between
infection with Beijing genotype and human CD209 e336A/G
polymorphism. The frequency of e336G allele was signifi-
cantly lower among the patients affected with Beijing
strains than among those infected with non-Beijing strains.
In another study, they investigated a possible combination
of M. tuberculosis lineage and human host allele/genotype
correlating with adverse outcome of the disease.14 They
proposed that although carriers of the CD209 e336A allele
are more sensitive to infection with a Beijing strain, a
combination of human CD209 e336G allele and M. tuber-
culosis Beijing genotype leads more frequently to lethal
outcomes in pulmonary TB male patients in Caucasian
population.14
It has been proposed that e336A/G variant in the CD209
(DC-SIGN) gene promoter region regulates promoter activ-
ity by affecting a Sp1-like binding site.12
Although the data indicated a discrepancy, both studies
suggested an important role of e366 A/G polymorphism of
CD209 in the development of TB. There is no clear expla-
nation for the different findings in different studies. Ethnic,
genetic, and/or environmental factors may interact in
various ways to either decrease or increase the suscepti-
bility to TB in different regions.25
This is the first report regarding the association between
e366 A/G polymorphism of CD209 and PTB in Iranian
population.
In conclusion, our results indicate that CD209 rs4804803
polymorphism increased the risk of PTB in a sample of
Iranian population. Larger studies are needed to validate
our findings.Conflicts of interest
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